Search for: "Roxane Laboratories, Inc."
Results 21 - 40
of 55
Sorted by Relevance
|
Sort by Date
9 Dec 2010, 3:53 am
Braun Medical Inc., and Roxane Laboratories Inc. [read post]
20 Mar 2016, 9:06 pm
Roxane Laboratories Inc. 1:15-cv-00919; filed October 13, 2015 in the District Court of Delaware Vanda Pharmaceuticals Inc. v. [read post]
17 Jun 2014, 6:15 pm
(Endo) appeals from the [Southern District of New York]district court’s order denying its motions for a preliminary injunction to prevent Roxane Laboratories, Inc. [read post]
30 Sep 2019, 9:02 am
Roxane Laboratories, Inc., No. 18-1280 (When should the objective indicia of nonobviousness be discounted based upon alleged “blocking” by an existing prior patent). [read post]
9 Apr 2019, 8:03 pm
Roxane Laboratories, Inc. [read post]
30 Aug 2016, 6:49 am
Roxane Laboratories, Inc., 1-13-cv-01973 (DED August 25, 2016, Order) (Sleet, USDJ) [read post]
25 Oct 2011, 3:26 am
The investigation determined that the pharmaceutical manufacturers Abbott Laboratories, Dey Inc. and Roxane Laboratories reported falsely inflated drug prices relied upon by the Medicare and Medicaid programs to determine reimbursements to pharmacies. [read post]
7 Dec 2010, 2:43 am
As for Roxane: Roxane is paying $280 million to resolve claims against it and related entities (Roxane Laboratories Inc., Boehringer Ingelheim Corp. and Boehringer Ingelheim Pharmaceuticals Inc.). [read post]
7 Apr 2007, 3:48 am
., sought and obtained a temporary restraining order (TRO), which was secured by a $3 million bond, enjoining the effectiveness of the approval by the Food and Drug Administration of an application by intervening defendant Roxane Laboratories, Inc. [read post]
24 Apr 2007, 9:06 am
Davis (approved for publication).In a follow-up to an earlier opinion (discussed here on this blog), an intervenor in the case, Roxane Laboratories, Inc. [read post]
21 Dec 2010, 10:08 am
Braun Medical Inc. and Roxane Laboratories Inc.The difference between the inflated amount the government paid and the actual price paid by health care providers for a drug is referred to as the “spread. [read post]
8 Oct 2019, 9:44 am
Roxane Laboratories, Inc., No. 18-1280 (obviousness and secondary indicia) Hyatt v. [read post]
18 May 2010, 3:19 pm
Roxane Laboratories, Inc. and Apotex, Inc. have appealed to the D.C. [read post]
19 Nov 2012, 4:00 am
Before issuing its decision, FDA received and considered public comment from Roxane Laboratories ("Roxane"), who had an Abbreviated New Drug Application ("ANDA") referencing Xyrem accepted for review in late 2010. [read post]
16 Sep 2011, 11:02 am
The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
6 Jul 2010, 11:03 am
District Court for the District of Columbia’s April 2, 2010 order denying motions for preliminary injunction filed by Roxane Laboratories, Inc. and Apotex, Inc. concerning 180-day exclusivity for generic versions of Merck’s COZAAR and HYZAAR (i.e., losartan). [read post]
9 Apr 2010, 8:30 am
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
20 Dec 2010, 8:05 pm
Braun Medical Inc. and Roxane Laboratories Inc. [read post]
11 Apr 2008, 3:00 am
Nabi sold its PhosLo drug product to Fresenius USA Manufacturing, Inc. [read post]
13 Dec 2010, 4:55 pm
District Court for the District of Columbia’s April 2, 2010 order denying motions for preliminary injunction filed by Roxane Laboratories, Inc. [read post]
